Autopsy report · NCT00003378
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
Cause of deathNo reason given
Life of this trial
- Registered 1 year 3 months after it had already started.
- 45 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Gynecologic Oncology Group
- Sponsor type
- University, hospital or other
- Conditions
- Ovarian Cancer; Primary Peritoneal Cavity Cancer
- Interventions
- carboplatin; gemcitabine hydrochloride; paclitaxel
- Participants
- 45 (planned, not actual)
- Sites
- 64
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.